Healthcare and Disease Control Measures in Ophthalmology

Dear Colleagues,

Ocular diseases affect one of the five senses and, if not diagnosed and treated, have a very negative impact on the daily life of patients who are affected, to the point of modifying their quality of life. In particular, there are two very frequent pathologies that mainly affect the elderly population without sparing even middle age: glaucoma and maculopathies.

These conditions must be sought, recognized, diagnosed early, and promptly treated to allow those affected not to have consequences on their visual and physical autonomy. It is important to conduct screening programs, periodic follow-up visits, as well as to prescribe rational, adequate, effective, scientifically evident and proven therapies, or to undertake adequate surgical or para-surgical treatments.

The COVID-19 pandemic has negatively affected the frequency of visits and the regularity of treatments; in some cases, it has led to significant visual impairment clearly demonstrating the importance of screening programs and ophthalmological disease control measures.

Original articles and reviews on the prevention of blindness will be considered, as well as risk assessment in health screening, adequate follow-up examinations, and appropriate frequency of therapies. Particularly welcome are publications that address the issues of preventing blindness from glaucoma or macular diseases, screening programs to identify and treat these pathologies early, strategies for carrying out visits, and treatments on schedule even in emergency situations.

The objective of the Special Issue is to provide an updated overview of the programs in progress for the prevention of visual impairment in glaucoma and maculopathies, focusing on new and emerging problems; furthermore, the aim is to provide suggestions on prevention to be developed and implemented to promote the health of patients with ocular disorders and to regularly carry out the treatments necessary to maintain good eyesight.

Dr. Gemma Caterina Maria Rossi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• glaucoma
• macular disease
• diabetic retinopathy
• screening programs
• intravitreal injection
• prevention
• healthcare
• eye disease control measures